Latest stories on ACIU
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
Business Insider56 · neutralproduct/pr
AC Immune: Holding Into A Make-Or-Break H2 2026 Readout
Seeking Alpha53 · neutralgeneral
AC Immune Unveils 12-Month Interim Data from ACI-24 Alzheimer’s Trial and Expands Takeda-Backed Program
TipRanks63 · neutralproduct/pr
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease | ACIU Stock News
StockTitan63 · neutralproduct/pr
AC Immune Secures $4 Million Goradia Foundation Grant to Extend Phase 2 Parkinson’s Trial
TipRanks63 · neutralgeneral